These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18458051)

  • 41. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables.
    Mazza A; Bendini MG; Cristofori M; Nardi S; Leggio M; De Cristofaro R; Giordano A; Cozzari L; Giordano G; Cappato R
    Europace; 2009 Jul; 11(7):902-9. PubMed ID: 19443431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between peripheral arterial disease and metabolic syndrome.
    Maksimovic M; Vlajinac H; Radak D; Marinkovic J; Jorga J
    Angiology; 2009; 60(5):546-53. PubMed ID: 19147526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.
    Lisboa T; Seligman R; Diaz E; Rodriguez A; Teixeira PJ; Rello J
    Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
    Bagheri N; Taziki O; Falaknazi K
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity.
    Horinaka S; Yabe A; Yagi H; Ishimura K; Hara H; Iemua T; Matsuoka H
    Angiology; 2009; 60(4):468-76. PubMed ID: 19015165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The JUPITER trial: How will it change clinical practice?
    Watson KE
    Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study.
    Brevetti G; Giugliano G; Oliva G; Lanero S; De Maio JI; Chiariello M
    QJM; 2008 Jul; 101(7):575-82. PubMed ID: 18463142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic value of impaired walking distance on long-term outcome in patients with known or suspected peripheral arterial disease.
    de Liefde II; Hoeks SE; van Gestel YR; Klein J; Bax JJ; Verhagen HJ; van Domburg RT; Poldermans D
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):482-7. PubMed ID: 19586784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
    Fonseca FA; Izar MC
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1041-56. PubMed ID: 19764857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased apoB/apoA-I ratio is predictive of peripheral arterial disease in initially healthy 58-year-old men during 8.9 years of follow-up.
    Johansson L; Schmidt C
    Angiology; 2009; 60(5):539-45. PubMed ID: 19022789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C-reactive protein incites atherosclerosis.
    Verma S
    Can J Cardiol; 2004 Aug; 20 Suppl B():29B-31B. PubMed ID: 15309202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hum Hypertens; 2008 Sep; 22(9):634-40. PubMed ID: 18528412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C-reactive protein (CRP) as a marker in peripheral vascular disease.
    Abdellaoui A; Al-Khaffaf H
    Eur J Vasc Endovasc Surg; 2007 Jul; 34(1):18-22. PubMed ID: 17296319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.
    Hage FG; Szalai AJ
    J Am Coll Cardiol; 2007 Sep; 50(12):1115-22. PubMed ID: 17868801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between protein-bound sialic acid and high-sensitivity C-reactive protein in essential hypertension: a possible indication of underlying cardiovascular risk.
    Sathiyapriya V; Nandeesha H; Selvaraj N; Bobby Z; Agrawal A; Pavithran P
    Angiology; 2008 Dec-2009 Jan; 59(6):721-6. PubMed ID: 18388037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.